BFS(Blow-fill-seal) 기술 시장 예측(-2030년) : 제품별, 재료별, 최종사용자별, 지역별 세계 분석

According to Stratistics MRC, the Global Blow-fill-seal Technology Market is accounted for $386.00 million in 2023 and is expected to reach $632.10 million by 2030 growing at a CAGR of 7.3% during the forecast period. Blow-fill-seal (BFS) technology is a highly efficient manufacturing process used in the pharmaceutical and packaging industries to produce small, sealed containers. It involves the simultaneous blowing of a container, filling it with the desired product (such as liquid medications or sterile solutions), and sealing it in a continuous, automated process. This method offers numerous advantages, including minimized contamination risk, increased product stability, and enhanced shelf life. BFS technology is widely favored for its ability to produce single-dose units quickly and with high precision, making it ideal for a range of applications, from eye drops to inhalation solutions.

According to a study by IMS Health, the improper use of medications by patients costs the U.S. healthcare system more than 210 billion dollars annually.

Market Dynamics:

Driver:

Increasing demand for sterile packaging

The increasing demand for sterile packaging is a key driver propelling the growth of the blow-fill-seal (BFS) technology market. This demand stems from various industries, such as pharmaceuticals, healthcare, and food and beverage, where maintaining product integrity and safety is paramount. BFS technology offers a seamless, sterile packaging solution by forming containers, filling them with the product, and sealing them in a single continuous process, minimizing the risk of contamination. As regulations become stricter and consumer awareness rises regarding the importance of sterile packaging, the BFS market experiences a surge due to its efficiency and reliability in ensuring product sterility and safety.

Restraint:

Limited compatibility

The limited compatibility restraints are due to inabilities to handle certain types of formulations or products. While BFS is highly versatile, accommodating a wide range of liquid formulations, it faces challenges with highly viscous substances or those containing particulate matter. This limitation arises from the nature of the process, which relies on molding and filling containers simultaneously. Products with incompatible viscosities or compositions may not flow smoothly through the machinery or may cause blockages, leading to inefficiencies or potential product defects. Consequently, manufacturers may need to invest in alternative packaging solutions for such formulations.

Opportunity:

Pharmaceutical industry expansion

The pharmaceutical industry is poised for significant expansion with the adoption of blow-fill-seal (BFS) technology. This innovative method integrates container forming, filling, and sealing in a single continuous process, offering advantages such as reduced contamination risk, enhanced product stability, and increased production efficiency. As demand for sterile and convenient packaging solutions grows, BFS presents a compelling opportunity for pharmaceutical companies to streamline manufacturing, ensure product integrity, and meet stringent regulatory requirements. Furthermore, BFS technology allows for the production of complex container designs, catering to diverse medication needs and enhancing market competitiveness.

Threat:

Supply chain disruptions

Supply chain disruptions pose a significant threat due to its intricate manufacturing process and reliance on specialized raw materials. Any disruption in the procurement of these materials or equipment can lead to production delays, affecting the supply of BFS products. Additionally, transportation challenges and border restrictions can hinder the distribution of BFS products to consumers, further exacerbating supply chain issues. These disruptions can result in increased costs, reduced product availability, and a potential loss of market share for BFS technology providers. Therefore, effective risk management strategies and the diversification of suppliers are crucial to mitigating the impact of supply chain disruptions on.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the blow-fill-seal (BFS) technology market. With increased focus on hygiene and safety, BFS technology, known for its ability to produce sterile and tamper-evident packaging, experienced a surge in demand, particularly in the pharmaceutical and healthcare sectors. However, disruptions in the global supply chain and manufacturing processes due to lockdowns and restrictions led to challenges in production and distribution, affecting market growth. Despite these obstacles, the need for efficient and aseptic packaging solutions in the healthcare industry propelled the BFS technology market forward, with companies adapting to meet the heightened demand and ensuring uninterrupted supply chains where possible.

The injectables segment is expected to be the largest during the forecast period

The growth in the injectables segment of the blow-fill-seal (BFS) technology market can be attributed to several factors. BFS technology offers numerous advantages, such as reduced risk of contamination, improved product stability, and increased efficiency in production processes, making it particularly suitable for injectable products. Additionally, the rising demand for sterile pharmaceutical packaging solutions, driven by stringent regulatory requirements and an increasing emphasis on patient safety, fuels the adoption of BFS technology. The scalability and cost-effectiveness of BFS technology also contribute to its popularity among pharmaceutical manufacturers, especially for injectable products where sterility and precision are paramount.

The pharmaceutical segment is expected to have the highest CAGR during the forecast period

The pharmaceutical segment's growth is driven by its offering advantages like reduced contamination risk and improved sterility assurance, aligning well with pharmaceutical industry standards for safety and quality. Additionally, its capability for rapid production and cost-effectiveness appeal to pharmaceutical manufacturers aiming for efficiency and scalability. The increasing demand for unit dose packaging, especially for injectable drugs and eye drops, further propels the adoption of BFS technology in the pharmaceutical sector. Moreover, as regulatory standards tighten, BFS's ability to meet stringent regulatory requirements enhances its attractiveness to pharmaceutical companies seeking compliance.

Region with largest share:

The blow-fill-seal (BFS) technology market in North America has experienced significant growth due to increasing demand for efficient and cost-effective packaging solutions in the pharmaceutical and healthcare industries. Additionally, the region's robust manufacturing infrastructure and technological advancements have facilitated the widespread implementation of BFS technology across various sectors. Stringent regulations regarding product safety and hygiene have further propelled market growth, as BFS technology offers superior protection against contamination. Furthermore, the rising prevalence of chronic diseases and the subsequent surge in pharmaceutical production have fuelled the demand for BFS packaging solutions in North America.

Region with highest CAGR:

The Asia-Pacific region has witnessed significant growth due to several factors increasing demand for pharmaceuticals and personal care products that has driven the adoption of BFS technology for efficient and sterile packaging. Additionally, the region's rapid industrialization and urbanization have led to a burgeoning middle class with higher disposable income, fueling demand for healthcare and beauty products. Governments in countries like China and India are investing in healthcare infrastructure, stimulating the BFS technology market's expansion. Furthermore, the Asia Pacific region presents fertile ground for BFS technology market growth, driven by burgeoning demand, supportive policies, and evolving consumer preferences.

Key players in the market

Some of the key players in Blow-fill-seal Technology market include Amanta Healthcare Ltd, Asept Pak, Inc, Brevetti Angela, Catalent. Inc., Curida AS, GlaxoSmithKline plc, Horizon Pharmaceuticals, Inc, Nephron Pharmaceuticals Corporation, New Vision Pharmaceuticals LLC, Recipharm AB, Rommelag SE & Co. KG, SIFI S.p.A, Takeda Pharmaceutical Company Limited, Unicep Packaging, Unipharma and Woodstock Sterile Solutions.

Key Developments:

In May 2024, Catalent Inc., a global CDMO headquartered in New Jersey, and Novo Holdings, a holding and investment company responsible for managing the assets and wealth of the Novo Nordisk Foundation, have entered into a merger agreement under which Novo Holdings will acquire Catalent in an all-cash transaction that values Catalent at $16.5 billion on an enterprise value basis.

In March 2024, Veeva Systems reported that Recipharm, a global contract development and manufacturing organization (CDMO), will use Veeva Vault QMS, Veeva Vault QualityDocs, and Veeva Vault Training to streamline its quality operations. Recipharm will leverage Veeva quality applications to help achieve greater quality oversight, use resources more effectively, accelerate validation, and maintain inspection readiness.

Products Covered:

• Vials
• Pre-Filled Syringes
• Bottles
• Ampoules
• Injectables
• Other Products

Materials Covered:

• Polyethylene
• Polypropylene
• Other Materials

End Users Covered:

• Food & Beverages
• Pharmaceutical
• Cosmetics & Personal Care
• Chemical
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Blow-fill-seal Technology Market, By Product

• 5.1 Introduction
• 5.2 Vials
• 5.3 Pre-Filled Syringes
• 5.4 Bottles
• 5.5 Ampoules
• 5.6 Injectables
• 5.7 Other Products

6 Global Blow-fill-seal Technology Market, By Material

• 6.1 Introduction
• 6.2 Polyethylene
  • 6.2.1 Low-Density Polyethylene
  • 6.2.2 High-Density Polyethylene
• 6.3 Polypropylene
• 6.4 Other Materials

7 Global Blow-fill-seal Technology Market, By End User

• 7.1 Introduction
• 7.2 Food & Beverages
• 7.3 Pharmaceutical
  • 7.3.1 Biologics
  • 7.3.2 Ophthalmic
  • 7.3.3 Wound Care
  • 7.3.4 Respiratory
• 7.4 Cosmetics & Personal Care
• 7.5 Chemical
• 7.6 Other End Users

8 Global Blow-fill-seal Technology Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 Amanta Healthcare Ltd
• 10.2 Asept Pak, Inc
• 10.3 Brevetti Angela
• 10.4 Catalent. Inc.
• 10.5 Curida AS
• 10.6 GlaxoSmithKline plc
• 10.7 Horizon Pharmaceuticals, Inc
• 10.8 Nephron Pharmaceuticals Corporation
• 10.9 New Vision Pharmaceuticals LLC
• 10.10 Recipharm AB
• 10.11 Rommelag SE & Co. KG
• 10.12 SIFI S.p.A
• 10.13 Takeda Pharmaceutical Company Limited
• 10.14 Unicep Packaging
• 10.15 Unipharma
• 10.16 Woodstock Sterile Solutions